CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS

Clinical trials for CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS trials appear

Sign up with your email to follow new studies for CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early cancer drug trial halted after testing in just 3 patients

Disease control Terminated

This was a very early, first-in-human study to test the safety and find the right dose of an experimental drug called AMG 794. It was for adults with advanced or spreading cancers that have a specific marker called Claudin 6 (CLDN6), including certain lung and ovarian cancers. Th…

Matched conditions: CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS

Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control

Last updated Apr 01, 2026 14:40 UTC

CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS

Get alerted when new CLAUDIN 6-POSITIVE ADVANCED/METASTATIC MALIGNANT SOLID TUMORS trials appear

Early cancer drug trial halted after testing in just 3 patients